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Purpose: Little information is available on the influence of diabetes mellitus on the 
short-term clinical outcomes of patients with bleeding peptic ulcers. The aim of this 
study is to investigate whether diabetes mellitus influences the short-term clinical 
outcomes of patients with bleeding peptic ulcers using a Japanese national adminis-
trative database. Materials and Methods: A total of 4863 patients treated by endo-
scopic hemostasis on admission for bleeding peptic ulcers were referred to 586 par-
ticipating hospitals in Japan. We collected their data to compare the risk-adjusted 
length of stay (LOS) and in-hospital mortality of patients with and without diabetes 
mellitus within 30 days. Patients were divided into two groups: patients with diabe-
tes mellitus (n=434) and patients without diabetes mellitus (n=4429). Results: 
Mean LOS in patients with diabetes mellitus was significantly longer than those 
without diabetes mellitus (15.8 days vs. 12.5 days, p<0.001). Also, higher in-hospi-
tal mortality within 30 days was observed in patients with diabetes mellitus com-
pared with those without diabetes mellitus (2.7% vs. 1.1%, p=0.004). Multiple lin-
ear regression analysis revealed that diabetes mellitus was significantly associated 
with an increase in risk-adjusted LOS. The standardized coefficient was 0.036 days 
(p=0.01). Furthermore, the analysis revealed that diabetes mellitus significantly in-
creased the risk of in-hospital mortality within 30 days (odds ratio=2.285, 95% 
CI=1.161-4.497, p=0.017). Conclusion: This study demonstrated that presence of 
diabetes mellitus significantly influences the short-term clinical outcomes of pa-
tients with bleeding peptic ulcers.
Key Words:    Bleeding peptic ulcers, diabetes mellitus, health care quality, retro-
spective studies, databases
INTRODUCTION
Bleeding peptic ulcers are one of the most frequently encountered emergency con-
ditions in daily practice for clinicians.1,2 The incidence of bleeding peptic ulcers 
patients with several chronic conditions has been increasing as a result of the aging 
of society in developed countries.3-5 In a recent report concerning bleeding peptic 
ulcers, Theocharis, et al.3 reported that the proportion of patients with chronic con-Atsuhiko Murata, et al.
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ternational Classification of Diseases and Injuries (ICD)-
10th. In addition, this administrative database also contains 
detailed patients’ information, such as all surgical proce-
dures and medications that have been indexed in the origi-
nal code. These codes are determined by the Ministry of 
Health, Labor and Welfare of Japan. The administrative da-
tabase associated with the DPC system also includes the 
quantity and date of all care delivered on a daily basis.10-12
Study setting
We selected 4863 patients treated by endoscopic hemosta-
sis on admission for bleeding peptic ulcers in 586 DPC par-
ticipating hospitals (55 academic and 531 community hospi-
tals) between April and December in 2008. These hospitals 
are dispersed throughout Japan and play a leading role in 
providing acute care medicine, advancing medical research, 
and educating students and medical residents.10-12
Using the data of comorbidities in the administrative data-
base, patients were divided into two groups according to the 
presence of diabetes mellitus: patients with diabetes mellitus 
(n=434) and patients without diabetes mellitus (n=4429). In 
the present study, diabetes mellitus was defined as code 
E10-E14 (insulin dependent, non-insulin dependent, malnu-
trition-related diabetes mellitus, other specified diabetes, and 
other non-specified diabetes) in the ICD-10th.
The use of DPC data was permitted by all institution and 
hospitals that provided detailed data. The research protocol 
of the study was approved by the ethics committee of medi-
cal care and research of the University of Occupational and 
Environmental Health, Kitakyushu, Japan.
Study variables
We collected data in the administrative database with re-
gard to the clinical characteristics of patients as follows: 
causes of bleeding peptic ulcers, gender, chronic comorbid 
conditions, sex, hospital type, use of ambulance transporta-
tion, use of a proton pump inhibitor, antiplatelet and antico-
agulation drugs, frequencies of endoscopic hemostasis for 
recurrent bleeding and salvage surgery after endoscopic he-
mostasis, length of stay (LOS) and in-hospital mortality 
within 30 days after admission.
The causes of the bleeding peptic ulcers were defined in 
accordance with the ICD-10th: hemorrhagic gastric ulcer 
(K25.0, K25.2, K25.4 and K25.6) and hemorrhagic duodenal 
ulcer (K26.0, K26.2, K26.4 and K26.6). Elderly patients 
have a higher risk of recurrent bleeding or death than young-
er patients, and the patients were therefore stratified by age 
ditions had increased between 1995 and 2005 in Greece. 
Furthermore, some previous studies have suggested that the 
presence of chronic conditions is significantly associated 
with the clinical outcomes of patients with bleeding peptic 
ulcers.4,5
Many researchers have investigated the influence of dia-
betes mellitus on clinical outcomes of patients with certain 
medical conditions or surgical procedures.6-9 In particular, 
many previous reports have shown strong associations be-
tween diabetes mellitus and cardiovascular diseases or inter-
ventional procedures, such as acute myocardial infarction or 
coronary stent implantation, and concluded that diabetes 
mellitus significantly influences the short-term clinical out-
comes of patients with cardiac disease or procedure.8,9 It is 
plausible that diabetes mellitus is an independent predictor 
for the short-term clinical outcomes of these patients.
However, little information is available on the influence of 
diabetes mellitus on the short-term clinical outcomes of pa-
tients with bleeding peptic ulcers. Establishment of a rela-
tionship between diabetes mellitus and the clinical outcomes 
of patients with bleeding peptic ulcers could contribute to 
future studies about bleeding peptic ulcers and have signifi-
cant implications for the quality of patient medical care.
In this study, we investigated the influence of diabetes mel-
litus on short-term clinical outcomes of patients with bleed-
ing peptic ulcers. This study was achieved using a national 
administrative database asscoaited with the Diagnosis Proce-
dure Combination (DPC) system.
MATERIALS AND METHODS
　　　
Administrative database associated with the DPC 
system
Japanese case mix projects based on the DPC system were 
introduced to 82 academic hospitals (80 university hospitals, 
the National Cancer Centre and the National Cardiovascular 
Centre) in 2003.10-12 Insurance reimbursement using the DPC 
system is quite prevalent in Japan, and the administrative da-
tabase of the DPC system has increased the representation of 
acute care hospitals. As of 2007, data from approximately 
450000 inpatients have been compiled, representing approxi-
mately 90% of all acute care inpatient hospitalizations.10-12
The administrative database of the DPC system includes 
each patient’s discharge summary and claim information, 
including principal diagnosis, comorbidities and complica-
tions during hospitalization. These data are coded in the In-Diabetes Mellitus and Outcomes of Bleeding Ulcers
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and additional factors related to LOS, such as causes of 
bleeding peptic ulcers, age, gender, hospital type, use of am-
bulance transportation, use of a proton pump inhibitor, anti-
platelet and anticoagulation drugs, and endoscopic hemosta-
sis and salvage surgery during hospitalization. Because the 
distribution of LOS was skewed to the right, LOS was log-
transformed in this model. Multiple logistic regression mod-
els were also used to identify the impact of the presence of 
diabetes mellitus on the in-hospital mortality within 30 days, 
considering the above factors. 
All statistical analysis was performed using the STATA 
statistical software package version 9.0 (Stata Corporation, 
College Station, TX, USA). Values of p<0.05 were consid-
ered to indicate statistical significance.
 
RESULTS
 
We identified a total of 4863 patients across 586 hospitals, 
comprising 3899 with hemorrhagic gastric ulcers, and 964 
with hemorrhagic duodenal ulcers. The clinical characteris-
tics and presentations of the patients are shown in Table 1. 
The mean age and proportions of elderly patients were sig-
into those aged <80 years and those aged ≥80 years, as de-
scribed in a previous study.13 To assess the severities of 
chronic comorbid conditions except for diabetes mellitus, we 
used the Charlson Comorbidity Index (CCI) for every patient 
using the administrative database.10-12 CCI was expressed as 
the score of comorbid conditions and was initially evaluated 
as a continuous variable. However, categorical variables de-
fining three categories of severity of comorbidity were creat-
ed to simplify the presentation of the results: 0, mild; 1, mod-
erate; and 2 or more, severe.10,11 Hospital type was classified 
as academic or community.10-12 In-hospital mortality within 
30 days was evaluated, rather than overall in-hospital mortal-
ity, because this measure eliminates potential bias due to dif-
ferences in LOS across hospitals and over time.14
Statistical analysis
The categorical data were compared using the chi-square 
test for categorical variables and the Mann-Whitney U test 
for continuous variables. In additional analyses, we used 
multiple linear regression models to identify the impact of 
the presence of diabetes mellitus on LOS, and addressed po-
tential confounding variables in the case mix data by con-
trolling for the severities of chronic comorbid conditions 
Table 1. Clinical Characteristics and Presentations of Patients according to the Presence of Diabetes Mellitus
Patients with DM Patients without DM p value
Number of patients 434 4429
Causes of the bleeding peptic ulcers (%)
    Hemorrhagic gastric ulcer 79.9 82.5 0.206
    Hemorrhagic duodenal ulcer 20.1 17.5
Mean age [yrs (SD)] 66.5 (18.1) 64.3 (17.8) 0.016
Elderly patients [≥80 yrs, (%)] 26.7 19.7 0.001
Severities of chronic comorbid conditions (%)
    Mild 39.4 45.3 0.062
    Moderate  44.9 40.7
    Severe 15.7 14.0
Male patients (%) 67.7 67.0 0.772
Hospital type (%)
    Academic hospitals   5.9   6.7 0.556
    Community hospitals 94.1 93.3
Use of ambulance transportation (%) 39.4 40.5 0.671
Use of proton pump inhibitor (%) 85.9 86.8 0.602
Use of antiplatelet drugs (%)   4.2   4.1 0.959
Use of anticoagulation drugs (%)   2.8   3.0 0.836
Endoscopic hemostasis for recurrent bleeding (%) 13.0 14.2 0.476
Salvage surgery after endoscopic hemostasis (%)   0.9   0.6 0.594
Mean length of stay [days (SD)] 15.8 (18.7) 12.5 (10.3) <0.001
In-hospital mortality within 30 days (%)   2.7   1.1 0.004
DM, diabetes mellitus; SD, standard deviation.Atsuhiko Murata, et al.
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with the in-hospital mortality within 30 days are demon-
strated in Table 3. In these analyses, diabetes mellitus sig-
nificantly increased the risk of in-hospital mortality within 
30 days [odds ratio (OR)=2.285, 95% CI=1.161-4.497, p= 
0.017]. Also, elderly patients, severe comorbid conditions, 
use of anticoagulation drugs, and salvage surgery after en-
doscopic hemostasis were associated with increased risks 
of in-hospital mortality within 30 days (OR: 2.138, 2.869, 
2.835 and 10.546, respectively).
DISCUSSION
We conducted this study to investigate the influence of dia-
betes mellitus on short-term clinical outcomes of patients 
with bleeding peptic ulcers using the Japanese administra-
tive database. The current study demonstrated that diabetes 
mellitus significantly increases in-hospital mortality and 
LOS in patients with bleeding peptic ulcers after adjustment 
for other chronic comorbid conditions and other factors.
Although there have been no studies with regard to LOS 
for the association between diabetes mellitus and bleeding 
peptic ulcers, our present findings about the influence of di-
abetes mellitus on in-hospital mortality to date are consis-
nificantly higher in patients with diabetes mellitus than those 
without diabetes mellitus. However, there were no significant 
differences between the two groups with regard to the pro-
portion of the severities of chronic comorbid conditions, 
male patients, hospital type, use of ambulance transportation, 
use of proton pump inhibitor, antiplatelet and anticoagulation 
drugs, endoscopic hemostasis and salvage surgery during 
hospitalization. Significant variation in mean LOS was ob-
served between groups (15.8±18.7 days in patients with dia-
betes mellitus vs. 12.5±10.3 days in patients without diabetes 
mellitus, p<0.001). Higher in-hospital mortality within 30 
days was observed in patients with diabetes mellitus than in 
those without diabetes mellitus (2.7% vs. 1.1%, p=0.004).
Multiple linear regression analyses of factors associated 
with the LOS are represented in Table 2. After adjustment 
for potentially confounding demographic and clinical vari-
ables, diabetes mellitus was significantly associated with an 
increased LOS. The standardized coefficient was 0.036 days 
(p=0.01). Elderly patients, ambulance transportation, endo-
scopic hemostasis for recurrent bleeding and salvage sur-
gery after endoscopic hemostasis were also significantly as-
sociated with an increased LOS (standardized coefficients: 
0.152, 0.042, 0.056 and 0.1, respectively).
Multiple logistic regression analyses of factors associated 
Table 2. Linear Regression Analysis of Factors Associated with Log-Transformed Length of Stay
Independent variables Unstandardized 
coefficient
95% confidence 
interval
Standardized 
coefficient p value
Intercept  2.173  (2.106, 2.241) <0.001
Diabetes mellitus
    Patients with DM (reference: patients without DM)  0.089  (0.021, 0.157)  0.036   0.010
Causes of the bleeding peptic ulcers
    Hemorrhagic duodenal ulcer (reference: gastric ulcer) -0.024 (-0.073, 0.023) -0.014   0.316
Age
    Elderly patients (reference: younger patients)  0.265  (0.215, 0.316)  0.152 <0.001
Chronic comorbid conditions
    Moderate -0.017 (-0.058, 0.024) -0.011   0.426
    Severe (reference: mild) -0.004 (-0.063, 0.054) -0.002   0.885
Sex
    Male (reference: female)  0.018 (-0.024, 0.061)  0.012   0.405
Hospital type
    Academic hospitals (reference: community hospitals) -0.070  (-0.148, 0.007) -0.025   0.075
Ambulance transportation  0.061  (0.021, 0.101)  0.042   0.002
Proton pump inhibitor  0.034 (-0.021, 0.090)  0.016   0.233
Antiplatelet drugs -0.009 (-0.107, 0.088) -0.002   0.848
Anticoagulation drugs  0.008 (-0.110, 0.128)  0.002   0.884
Endoscopic hemostasis for recurrent bleeding  0.117  (0.060, 0.175)  0.056 <0.001
Salvage surgery after endoscopic hemostasis   0.739  (0.537, 0.942)  0.100 <0.001
DM, diabetes mellitus.Diabetes Mellitus and Outcomes of Bleeding Ulcers
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crease of in-hospital mortality and LOS may be explained 
by several factors. First, with regard to the association be-
tween diabetes mellitus and increased in-hospital mortality 
of patients with bleeding peptic ulcers, several studies sug-
gested that diabetic angiopathy impairs mucosal integrity, 
leading to more severe ulcers,15,16 and that diabetes mellitus 
increases susceptibility to acute gastrointestinal injury and 
impairs mucosal healing.17,18 Therefore, the angiopathy re-
lated to diabetes mellitus may make the control of bleeding 
from the lesions more difficult and may influence in-hospi-
tent with some previous studies.15,16 In a population-based 
cohort study in Denmark, Thomsen, et al.15 reported that 
the adjusted 30 days mortality rate ratio for bleeding peptic 
ulcer patients with diabetes mellitus to those without diabe-
tes was 1.40 (95% CI=1.15-1.70). In a case-control study in 
the UK, Weil, et al.16 also reported that diabetes mellitus 
was a significant factor for poor outcomes of patients with 
peptic ulcer bleeding associated with non-steroidal anti-in-
flammatory drugs (OR=3.1, 95% CI=1.2-4.3).
The associations between diabetes mellitus and the in-
Table 3. Logistic Regression Analyses of Factors Associated with In-Hospital Mortality Within 30 Days
Independent variables Odds ratio 95% confidence interval p value
Diabetes mellitus
    Patients with DM 2.285 (1.161, 4.497) 0.017
    Patients without DM 1.000 (reference)
Causes of the bleeding peptic ulcers
    Hemorrhagic duodenal ulcer 0.948 (0.486, 1.847) 0.876
    Hemorrhagic gastric ulcer 1.000 (reference)
Age
    Elderly patients 2.138 (1.195, 3.827) 0.010
    Younger patients 1.000 (reference)
Chronic comorbid conditions
    Moderate 1.769 (0.940, 3.328) 0.077
    Severe 2.869 (1.407, 5.849) 0.004
    Mild 1.000 (reference)
Sex
    Male 0.840 (0.478, 1.475) 0.545
    Female 1.000 (reference)
Hospital type
    Academic hospitals 0.876 (0.270, 2.838) 0.826
    Community hospitals 1.000 (reference)
Ambulance transportation
    Used 0.970 (0.567, 1.660) 0.914
    Not used 1.000 (reference)
Proton pump inhibitor
    Used  0.646 (0.330, 1.264) 0.202
    Not used  1.000 (reference)
Antiplatelet drugs
    Used  0.693 (0.160, 2.999) 0.625
    Not used  1.000 (reference)
Anticoagulation drugs
    Used  2.835 (1.048, 7.668) 0.040
    Not used  1.000 (reference)
Endoscopic hemostasis for recurrent bleeding
    Performed  0.430 (0.153, 1.205) 0.109
    Not performed 1.000 (reference)
Salvage surgery after endoscopic hemostasis
    Performed  10.546 (3.446, 32.268) <0.001
    Not performed 1.000 (reference)
DM, diabetes mellitus.Atsuhiko Murata, et al.
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tients minimizes any bias due to differences in the bleeding 
conditions of bleeding peptic ulcers, because almost all the 
patients were considered to be in a temporary hemostatic 
condition (in other words, almost all the patients were in 
the same condition at the baseline). For this reason, we be-
lieve that the administrative database used does not dimin-
ish the reliability of the present study.
Despite this limitation, the current study has implications 
for future research about the quality of patient care and 
health care policy decision making. The current study con-
firmed that diabetes mellitus significantly contributes to in-
creased mortality and prolonged LOS of patients with bleed-
ing peptic ulcers. Therefore, policy implementation of more 
appropriate medical treatments is necessary to achieve better 
clinical outcomes in patients with bleeding peptic ulcers and 
diabetes mellitus. One strategy for improving care for pa-
tients would be disease management programs, such as clin-
ical practice guidelines (CPGs). As an example, CPGs for 
cardiovascular diseases in diabetes mellitus have been de-
veloped.24 These CPGs contain detailed practical instruc-
tions for management of cardiovascular diseases in diabetic 
patients.24 Some studies have reported that CPGs can im-
prove the health outcomes of patients in terms of in-hospital 
mortality or LOS and concluded that CPGs were a signifi-
cant independent predictor of clinical outcomes of pa-
tients.25,26 Therefore, we think that the preparation and insti-
tution of CPGs for bleeding peptic ulcers with comorbid 
diabetes mellitus would be a promising policy implementa-
tion for improving the short-term clinical outcomes of these 
patients. In addition, prospective monitoring of clinical out-
comes of patients after introduction of CPGs should also be 
conducted in the future.
In conclusion, we have demonstrated that the presence of 
diabetes mellitus significantly influences the short-term clini-
cal outcomes of patients with bleeding peptic ulcers using a 
national administrative database. The current findings could 
contribute to the policy implementation of disease manage-
ment programs in patients with bleeding peptic ulcers and di-
abetes mellitus. To achieve better clinical outcomes for dia-
betic patients with bleeding peptic ulcers, CPGs for more 
appropriate medical treatments may be required in the future.
ACKNOWLEDGEMENTS
This study was funded by Grants-in-Aid for Research on 
Policy Planning and Evaluation from the Ministry of Health, 
tal mortality of patients with bleeding peptic ulcers. Sec-
ond, with regard to the association between diabetes melli-
tus and prolonged LOS, one possible explanation is that 
hospitalization was prolonged by high levels of blood sugar 
associated with hemorrhage from upper gastrointestinal le-
sions. Faigel, et al.19 reported that the glucose concentra-
tions of patients with diabetic ketoacidosis were significant-
ly elevated in cases of upper gastrointestinal hemorrhage. 
In addition, Bhatia, et al.20 concluded that the admission 
and in-hospital blood glucose levels strongly positively cor-
related with the number of days of hospitalization. Several 
studies also showed a strong association between hypergly-
cemia and prolonged hospitalization.21-23 Therefore, the 
hemorrhage from the lesions may contribute to the tempo-
rary high levels of blood sugar and lead to time-consuming 
glycemic control. As a consequence, LOS is prolonged in 
patients with bleeding peptic ulcers. These putative mecha-
nisms may help explain the short-term clinical outcomes 
among patients with diabetes mellitus.
The strength of this study is its use of the clinical data-
base. This administrative database can allow the assessment 
of a large number of patients, as well as the enrollment of a 
representative sample of patients with bleeding peptic ulcers 
for analysis in a community setting.10-12 In addition, detailed 
medical data during hospitalizations such as all procedures 
and medications have been thoroughly coded.10-12 This ad-
ministrative database therefore enables a detailed evaluation 
of the quality of care and clinical outcomes, based on indi-
vidual medical treatments for bleeding peptic ulcers with di-
abetes mellitus.
Several limitations of this study also warrant mention. 
First, we could not evaluate the history of diabetes mellitus 
or the circumstances of treatments for diabetes mellitus. 
Therefore, further clinical studies evaluating the relationship 
between diabetes mellitus and clinical outcomes in patients 
with bleeding peptic ulcers are required, taking account of 
the history or treatments of diabetes mellitus. Second, be-
cause this administrative database does not include endo-
scopic imaging data such as lesion size, stigmata of hemor-
rhage or laboratory test data such as hemoglobin, creatinine 
and blood urea nitrogen, we were unable to evaluate and 
control for some important clinical aspects of bleeding pep-
tic ulcers. These clinical aspects of bleeding peptic ulcers 
may influence LOS and/or in-hospital mortality of patients. 
However, the subjects of this study comprised patients treat-
ed by endoscopic hemostasis on admission for bleeding 
peptic ulcers. Therefore, we think that our selection of pa-Diabetes Mellitus and Outcomes of Bleeding Ulcers
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